• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viatris Inc. - Common Stock (NQ:VTRS)

    15.88 +0.31 (+2.02%)
    Streaming Delayed Price Updated: 2:37 PM EDT, Jun 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,871,259
    Open 15.70
    Bid (Size) 15.87 (1,500)
    Ask (Size) 15.88 (4,800)
    Prev. Close 15.56
    Today's Range 15.64 - 15.94
    52wk Range 8.400 - 17.53
    Shares Outstanding 1,212,301,241
    Dividend Yield 3.02%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
    Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
    Via StockStory
    News headline image
    Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?
    Viatris has been on fire lately. In the past six months alone, the company’s stock price has rocketed 58.2%, reaching $16.13 per share. This was partly thank... 
    Via StockStory

    Performance

    YTD
    +27.4%
    +27.4%
    1 Month
    +4.4%
    +4.4%
    3 Month
    +7.9%
    +7.9%
    6 Month
    +46.4%
    +46.4%
    1 Year
    +82.3%
    +82.3%

    More News

    Read More
    News headline image
    This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    1 Stock Under $50 to Target This Week and 2 We Avoid
    Via StockStory
    Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates ↗
    Via Chartmill
    News headline image
    5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    3 Unprofitable Stocks That Fall Short
    Via StockStory
    News headline image
    VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance
    Via StockStory
    News headline image
    Viatris (VTRS) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    These S&P500 stocks have an unusual volume in today's session ↗
    Via Chartmill
    What's going on in today's session: S&P500 gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Earnings To Watch: Viatris (VTRS) Reports Q1 Results Tomorrow
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Economy Government Stocks
    News headline image
    QSM Asset Management Loads Up 611,000 Mobileye Shares ↗
    Via The Motley Fool
    Topics Economy Regulatory Compliance Supply Chain
    News headline image
    A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
    Via StockStory
    News headline image
    This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
    Via The Motley Fool
    News headline image
    Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings?
    Via StockStory
    Topics Stocks
    News headline image
    Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
    Via Finterra
    Topics Economy Initial Public Offering Retirement
    News headline image
    Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4
    Via StockStory
    Topics Artificial Intelligence Intellectual Property

    Frequently Asked Questions

    Is Viatris Inc. - Common Stock publicly traded?
    Yes, Viatris Inc. - Common Stock is publicly traded.
    What exchange does Viatris Inc. - Common Stock trade on?
    Viatris Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viatris Inc. - Common Stock?
    The ticker symbol for Viatris Inc. - Common Stock is VTRS on the Nasdaq Stock Market
    What is the current price of Viatris Inc. - Common Stock?
    The current price of Viatris Inc. - Common Stock is 15.88
    When was Viatris Inc. - Common Stock last traded?
    The last trade of Viatris Inc. - Common Stock was at 06/04/26 02:37 PM ET
    What is the market capitalization of Viatris Inc. - Common Stock?
    The market capitalization of Viatris Inc. - Common Stock is 19.25B
    How many shares of Viatris Inc. - Common Stock are outstanding?
    Viatris Inc. - Common Stock has 19B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.